Ethnic-related differences in the frequency distribution of genetic polymorphisms in the CYP1A1 and CYP1B1 genes in Japanese and Caucasian populations

Xenobiotica

Volumn 30, Issue 3, 2000, Pages 285-295

  Inoue, K ^a   Asao, T ^a   Shimada, T ^a  

^a OSAKA PREFECTURAL INSTITUTE OF PUBLIC HEALTH   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

5,10 METHYLENETETRAHYDROFOLATE REDUCTASE (FADH2); CARCINOGEN; CYTOCHROME P450;

ARTICLE; ASIAN; CAUCASIAN; ETHNIC DIFFERENCE; GENE FREQUENCY; GENE MUTATION; GENETIC POLYMORPHISM; HUMAN; HUMAN TISSUE; LIVER;

EID: 0034029749     PISSN: 00498254     EISSN: None     Source Type: Journal    
DOI: 10.1080/004982500237677     Document Type: Article

References (37)

1. Aynacioglu, A. S., Cascorbi, I., Mrozikiewicz, P. M. and Ropp, J. D., 1998, High frequency of CYP1A1 mutations in a Turkish population. Archives of Toxicology, 72, 215-218.
2. Bailey, L. R., Roodi, N., Dupont, W. D. and Parl, F. F., 1998, Association of cytochrome P450 1B1 (CYP1B1) polymorphism with steroid receptor status in breast cancer. Cancer Research, 58, 5038-5041.
3. Bejjani, B. A., Lewis, R. A., Tomey, K. F., Anderson, K. L., Dueker, D. K., Jabak, M., Astle, W. F., Otterud, B., Leppert, M. and Lupski, J. R., 1998, Mutations in CYP1B1, the gene for cytochrome P4501B1, are the predominant cause of primary congenital glaucoma in Saudi Arabia. American Journal of Human Genetics, 62, 325-333.
4. Cascorbi, I., Brockmoller, J. and Roots, I., 1996, A C4887A polymorphism in exon 7 of human CYP1A1: population frequency, mutation linkages, and impact on lung cancer susceptibility. Cancer Research, 56, 4965-4969.
5. Cosma, G., Crofts, F., Taioli, E., Toniolo, P. and Garte, S., 1993, Relationship between genotype and function of the human CYP1A1 gene. Journal of Toxicology and Environmental Health, 40, 309-316.
6. Crofts, F., Cosma, G. N., Currie, D., Taioli, E., Toniolo, P. and Garte, S. J., 1993, A novel CYP1A1 gene polymorphism in African-Americans. Carcinogenesis, 14, 1729-1731.
7. D'Errico, A., Taioli, E., Chen, X. and Vineis, P., 1996, Genetic metabolic polymorphisms and the risk of cancer: a review of the literature. Biomarkers, 1, 149-173.
8. Drakoulis, N., Cascorbi, I., Brockmoller, J., Gross, C. R. and Roots, I., 1994, Polymorphisms in the human CYP1A1 gene as susceptibility factors for lung cancer: exon-7 mutation (4889 A to G), and a T to C mutation in the 3′-flanking region. Clinical Investigations, 72, 240-248.
9. Eltom, S. E., Larsen, M. C. and Jefcoate, C. R., 1998, Expression of CYP1B1 but not CYP1A1 by primary cultured human mammary stromal fibroblasts constitutively and in response to dioxin exposure: role of the Ah receptor. Carcinogenesis, 19, 1437-1444.
10. Esteller, M., Garcia, A., Martinez-Palones, J. M., Xercavins, J. and Reventos, J., 1997, Germ line polymorphisms in cytochrome P450 1A1 (C4887 CYP1A1) and methylenetetrahydrofolate reductase (MTHFR) genes and endometrial cancer susceptibility. Carcinogenesis, 18, 2307-2311.
11. Gonzalez, F. J. and Gelboin, H. V., 1994, Role of human cytochromes P450 in the metabolic activation of chemical carcinogens and toxins. Drug Metabolism Reviews, 26, 165-183.
12. Guengerich, F. P., Hosea, N. A., Parikh, A., Bell-Parikh, L. C., Johnson, W. W., Gillam, E. M. J. and Shimada, T., 1998, Twenty years of biochemistry of human P450s. Drug Metabolism and Disposition, 26, 1175-1178.
13. Guengerich, F. P. and Shimada, T., 1991, Oxidation of toxic and carcinogenic chemicals by human cytochrome P-450 enzymes. Chemical Research in Toxicology, 4, 391-407.
14. Hayashi, S., Watanabe, J. and Kawajiri, K., 1992, High susceptibility to lung cancer analyzed in terms of combined genotypes of P4501A1 and Mu-class glutathione S-transferase genes. Japanese Journal of Cancer Research, 83, 866-870.
15. Hayashi, S. I., Watanabe, J., Nakachi, K. and Kawajiri, K., 1991, Genetic linkage of lung cancer-associated Msp1 polymorphisms with amino acid replace'ment in the heme binding region of the human cytochrome P4501A1 gene. Journal of Biochemistry, 110, 407-411.
16. Hirvonen, A., Husgafvel-Pursiainen, K., Karjalainen, A., Anttila, S. and Vainio, H., 1992, Point-mutational Msp1 and He-Val polymorphisms closely linked in the CYP1A1 gene: lack of association with susceptibility to lung cancer in a Finnish study population. Cancer Epidemiology, Biomarkers and Prevention, 1, 485-489.
17. Huang, Z., Fasco, M. J., Figge, H. L., Keyomars, F. K. and Kaminsky, L. S., 1996, Expression of cytochromes P450 m human breast tissue and tumors. Drug Metabolism and Disposition, 24, 899-905.
18. Inoue, K., Yamazaki, H., Imiya, K., Akasaka, S., Guengerich, F. P. and Shimada, T., 1997, Relationship between CYP2C9 and 2C19 genotypes and tolbutamide methyl hydroxylation and S-mephenytoin 4′-hydroxylation activities in livers of Japanese and Caucasian populations. Pharmacogenetics, 7, 103-113.
19. Kawajiri, K., Nakachi, K., Imai, K., Yoshii, A., Shinoda, N. and Watanabe, J., 1990, Identification of genetically high risk individuals to lung cancer by DNA polymorphisms of the cytochrome P4501A1 gene. FEBS Letters, 263, 131-133.
20. Kawajiri, K., Watanabe, J. and Hayashi, S., 1996, Identification of allelic variants of the human CYP1A1 gene. Methods in Enzymology, 272, 226-232.
21. Kelsey, K. T., Wiencke, J. K. and Spitz, M. R., 1994, A race-specific genetic polymorphism in the CYP1A1 gene is not associated with lung cancer in African Americans. Carcinogenesis, 15, 1121-1124.
22. Kumeda, Y. and Asao, T., 1996, Single-strand conformation polymorphism analysis of PCR-amplified ribosomal DNA internal transcribed spacers to differentiate species of Aspergillus section Flavi. Applied and Environmental Microbiology, 62, 2947-2952.
23. Larsen, M. C., Angus, W. G. R., Brake, P. B., Elton, S. E., Sukow, K. A. and Jefcoate, C. R., 1998, Characterization of CYP1B1 and CYP1A1 expression in human mammary epithelial cells: role of the aryl hydrocarbon receptor in polycyclic aromatic hydrocarbon metabolism. Cancer Research, 58, 2366-2374.
24. Liehr, J. G. and Rocci, M. J., 1996, 4-Hydroxylation of estrogens as marker of human mammary tumors. Proceedings of the National Academy of Sciences, USA, 93, 3294-3296.
25. Nakachi, K., Imai, K., Hayashi, S. and Kawajiri, K., 1991, Genetic susceptibility to squamous cell carcinoma of the lung in relation to cigarette smoking dose. Cancer Research, 51, 5177-5180.
26. Nelson, D. R., Kamataki, T., Waxman, D. J., Guengerich, F. P., Estabrook, R. W., Feyereisen, R., Gonzalez, F. J., Coon, M. J., Gunsalus, I. C., Gotoh, O., Okuda, K. and Nebert, D. W., 1993, The P450 superfamily: update on new sequences, gene mapping, accession numbers, early trivial names of enzymes, and nomenclature. DNA and Cell Biology, 12, 1-51.
27. Nelson, D. R., Koymans, L., Kamataki, T., Stegeman, J. J., Feyereisen, R., Waxman, D. J., Waterman, M. R., Gotoh, O., Coon, M. J., Estabrook, R. W., Gunsalus, I. C. and Nebert, D. W., 1996, P450 superfamily: update on new sequences, gene mapping, accession numbers and nomenclature. Pharmacogenetics, 6, 1-42.
28. Shimada, T., Hayes, C. L., Yamazaki, H., Amin, S., Hecht, S. S., Guengerich, F. P. and Sutter, T. R., 1996, Activation of chemically diverse procarcinogens by human cytochrome P450 1B1. Cancer Research, 56, 2979-2984.
29. Shimada, T., Watanabe, J., Kawajiri, K., Sutter, T. R., Guengerich, F. P., Gillam, E. M. J. and Inoue, K., 1999, Catalytic properties of polymorphic human cytochrome P450 1B1 variants. Carcinogenesis, 20, 1607-1613.
30. Shimada, T., Wunsch, R. M., Hanna, I. H., Sutter, T. R., Guengerich, F. P. and Gillam, E. M. J., 1998, Recombinant human cytochrome P450 1B1 expression in Escherichia coli. Archives of Biochemistry and Biophysics, 357, 111-120.
31. Shimada, T., Yamazaki, H., Mimura, M., Inui, Y. and Guengerich, F. P., 1994, Interindividual variations in human liver cytochrome P-450 enzymes involved in the oxidation of drugs, carcinogens and toxic chemicals: studies with liver microsomes of 30 Japanese and 30 Caucasians. Journal of Pharmacology and Experimental Therapeutics, 270, 414-423.
32. Spink, D. C., Eugster, H. P., Lincoln H, D. W., Schuetz, J. D., Schuetz, E. G., Johnson, J. A., Kaminsky, L. S. and Gierthy, J. F., 1992, 17β-Estradiol hydroxylation catalyzed by human cytochrome P450 1A1 : a comparison of the activities induced by 2,3,7,8-tetrachlorodibenzo-p-dioxin in MCF-7 cells with those from heterologous expression of the cDNA. Archives of Biochemistry and Biophysics, 293, 342-348.
33. Spink, D. C., Spink, B. C., Cao, J. Q., Gierthy, J. F., Hayes, C. L., Li, Y. and Sutter, T. R., 1997, Induction of cytochrome P450 1B1 and catechol estrogen metabolism in ACHN human renal adenocarcinoma cells. Journal of Steroid and Biochemical Molecular Biology, 62, 223-232.
34. Sutter, T. R., Tang, Y. M., Hayes, C. L., Wo, Y.-Y. P., Jabs, W., Li, X., Yin, H., Cody, C. W. and Greenlee, W. F., 1994, Complete cDNA sequence of a human dioxin-inducible mRNA identifies a new gene subfamily of cytochrome P450 that maps to chromosome 2. Journal of Biological Chemistry, 269, 13092-13099.
35. Taioli, E., Crofts, F., Trachman, J., Bayo, S., Toniolo, P. and Garte, S. J., 1995, Racial differences in CYP1A1 genotype and function. Toxicology Letters, 77, 357-362.
36. Watanabe, J., Shimada, T., Gillam, E. M. J., Ikuta, T., Suematsu, K., Higashi, Y., Gotoh, O. and Kawajiri, K., 1999, Association of CYP1B1 genetic polymorphism with incidence to breast and lung cancer. Pharmacogenetics (in press).
37. Yamazaki, H., Inoue, K., Turvy, C. G., Guengerich, F. P. and Shimada, T., 1997, Effects of freezing, thawing, and storage of human liver samples on the microsomal contents and activities of cytochrome P450 enzymes. Drug Metabolism and Disposition, 25, 168-174.